期刊文献+

CD56在急性白血病细胞上的表达及其意义 被引量:8

Expression and Clinical Significance of CD56 Antigen in Acute Leukemia
下载PDF
导出
摘要 目的探讨CD56在急性白血病(AL)中的表达情况,分析CD56阳性急性髓系白血病(AML)和急性淋系白血病(ALL)患者的免疫表型特点。方法应用流式细胞术(FCM)检测76例急性白血病患者CD56的表达情况,分析CD56+AML和CD56+ALL的免疫表型特点。结果 CD56在AML患者中表达的比例为32.1%(18/56);在AML亚型中,CD56阳性患者在M1、M2、M3及M5中所占比例分别为33.3%(3/9)、47.6%(10/21)、9.1%(1/11)及28.6%(4/14)。CD56在ALL患者中表达的比例为30.0%(6/20);在T-ALL中,CD56阳性患者的比例为44.4%(4/9);10例B-ALL患者中有1例表达CD56,比例为10.0%;1例NK细胞白血病表达CD56。此外,与对照组相比,CD56+AML患者中CD33的表达率明显增加(P=0.021),而CD56+ALL患者中CD7的表达率亦明显增加(P=0.024)。结论伴CD56阳性的急性白血病细胞,其在各型白血病细胞中的免疫表型各有特点,多见于M2和T-ALL。且CD56+AML患者中CD33的表达率较高,CD56+ALL患者中CD7的表达率较高,研究结果将为CD56+AL患者的治疗和预后分析提供重要的指导意义。 Objective To investigate the expression of CD56 antigen in acute leukemia (AL),and to analyze the immune phenotype of CD56-positive acute myeloid leukemia (AML) and CD56-positive acute lymphoid leukemia (ALL).Methods The expression of CD56 in bone marrow of 76 AL patients was detected by flow cytometry(FCM).And the immune phenotype was analyzed in CD56-positive AML and CD56-positive ALL patients.Results The percentage of CD56 expression in AL patients was 32.1% (18/56).And in AML subtypes detected,the percentages of CD56 expression were 33.3%(3/9),47.0%(10/21),9.1%(1/11),and 28.6%(4/14) inM1,M2,M3andM5,respectively.The percentage of CD56 expression in ALL patients was 30.0% (6/20).In T-ALL subtype,the percentage of the CD56 expression was 44.4% (4/9),while the percentage of the CD56 expression was 10.0%(1/10) in B-ALL subtype.One case(1/1) of NK cell ALL was found to present CD56 expression.In addition,compared to respective control group,CD33 expression was significantly upregulated in CD56+AML patients(P=0.021),while CD7 was significantly upregulated in CD56+ALL patients (P=0.024).Conclusion The data suggest that the immunophenotype of AL patients with positively expressed CD56 is variable.And CD56 is more expressed in M2 and T-ALL patients.Moreover,in AML patients,CD56 expression is related to a significant expression of CD33,while in ALL patients,CD56 expression is associated with significant expression of CD7.Thus,this data contribute to the treatment and prognosis for acute leukemia.
出处 《临床输血与检验》 CAS 2014年第1期31-34,共4页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 CD56 急性髓系白血病 急性淋系白血病 免疫表型 CD56 Acute myeloid leukemia Acute lymphoid leukemia Immune phenotype
  • 相关文献

参考文献10

  • 1Alegretti AP,Bittar CM,Bittencourt R. The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia[J].Rev Bras Hematol Hemoter,2011,(3):202-206.
  • 2Djunic I,Virijevic M,Djurasinovic V. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia[J].{H}MEDICAL ONCOLOGY,2012,(3):2077-2082.
  • 3Dalmazzo LF,Jacomo RH,Marinato AF. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment[J].{H}British Journal of Haematology,2009,(2):223-229.
  • 4张之南.血液病诊断及疗效标准[M]北京:科学出版社,1998298.
  • 5Cannizzo E,Carulli G,Buda G. Meningeal relapse in a case of B acute lymphoblastic leukemia:the role of CD56 expression[J].{H}MEDICAL SCIENCE MONITOR,2009,(2):CS27-CS29.
  • 6Iriyama N,Hatta Y,Takeuchi J. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t (8;21)[J].{H}Leukemia Research,2013,(9):1021-1026.
  • 7Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies[J].{H}Blood,1996,(4):1207-1210.
  • 8Raspadori D,Damiani D,Lenoci M. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis[J].{H}LEUKEMIA,2001,(8):1161-1164.
  • 9Fischer L,Gokbuget N,Schwartz S. CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy[J].{H}HAEMATOLOGICA,2009,(2):224-229.
  • 10Gimenes-Teixeira HL,Lucena-Araujo AR,Dos Santos GA. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia[J].Exp Hematol Oncol,2013,(1):10.

同被引文献71

  • 1周峰,晁红颖,卢绪章,陈涛,杨建和,姜乃可,岑岭,周民.81例急性单核细胞白血病患者的分子遗传学研究[J].中华医学遗传学杂志,2019,36(6):556-560. 被引量:1
  • 2柏树令,赵丹.CD34抗原的生物学特性及其临床应用[J].解剖科学进展,2005,11(1):54-56. 被引量:40
  • 3王兴兵,姚军霞,郑金娥,刘隽,李小青,贺艳丽,喻竞明,杨晶,魏君,刘仲萍,黄士昂.115例急性髓细胞白血病多参数流式细胞术免疫表型分析[J].中国实验血液学杂志,2005,13(2):250-253. 被引量:20
  • 4李熙鸿,熊珍玉,王晓阳.儿童急性淋巴细胞白血病CD_(34)^+表达的临床意义[J].中华妇幼临床医学杂志(电子版),2006,2(3):140-142. 被引量:5
  • 5潘湘涛,李建勇,夏学鸣,薛永权.MIC分型评价成人急-性髓系白血病中的淋系抗原表达[J].肿瘤,2006,26(10):944-946. 被引量:12
  • 6Dunphy CH. Applications of flow cytometry and immunohistochemistryto diagnostic hematopathology [ J ] . Arch Pathol Lab Med,2004,128 (9): 1004-1022.
  • 7Kem W,Bacher U, Haferlach C, et al. Acute monoblastic/monocyticleukemia and chronic myelomonocytic leukemia share commonimmunophenotypic features but differ in the extent of aberrantlyexpressed antigens and amount of granulocytic cells [ J ] . LeukLymphoma, 2011,52 ( 1): 92-100.
  • 8Cazitt Y. Homing and mobilization of hematopoietic stem cells andhematopoietic cancer cells are mirror image processes, utilizingsimilar signaling pathways and occurring concurrently : circulatingcancer ceils constitute an ideal target for concurrent treatment withchemotherapy and antilineage-specific antibodies [ J] . Leukemia,2004, 18 (1): 1-10.
  • 9Hayden PJ, O* Connell NM, 0’ Brien DA, et al. The value ofautofluorescence as a diagnostic feature of acute promyelocyticleukemia [ J ] . HaematoLogica, 2006 , 91 ( 3 ) : 417-418.
  • 10Dunphy CH,Tang W. The value of CD64 expression in distinguishingacute myeloid leukemia with monocytic difTerentiation from othersubtypes of acute myeloid leukemia : a flow cytometric analysis of 64cases [ J ] . Arch Pathol Lab Med, 2007, 131 ( 5 ) : 748-754.

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部